If the host is infected with Schistosoma mansoni, Arg1 can effectively suppress Th2-mediated fibrosis, Th1/Th17-mediated intestinal damage, iNOS production, and endotoxemia (Pesce et al., 2009; Herbert et al., 2010). This evidence concerns the gene ARG1 and serum lipopolysaccharide activity.